Leading publicly traded Neuroscience company appoints global pharmaceutical veteran to their Board

by

Subscribe to receive industry-focused thought leadership and insights, delivered right to your inbox Subscribe

Bedford Group Transearch Life Sciences would like to congratulate Theresa Firestone on her appointment to the Board of Cybin (NYSE: CYBN).

Firestone joins the Board following a distinguished career as a senior healthcare executive with leadership positions in Canada, Europe and Asia. An expert in strategic planning, operations and new business development, her experience includes 20+ years of international P&L management, 15 years in senior roles at Pfizer (including 3 years as Regional President for Asia Emerging Markets)., over ten years at the Ontario Ministry of Health and seven years in retail and health and wellness, including Shoppers Drug Mart where she oversaw the design and launch of the company’s Medical Cannabis business. In addition, Ms. Firestone has more than 20 years of public and private board experience including with Orion Biotechnology, Merus Labs International and several not-for-profit organizations.

A link to the full release can be found here.

Steven Pezim

Steven Pezim

Co-Founder and Managing Director

Email: steven@bedfordgroup.com
Tel: 416-963-9000 x. 222
Howard Pezim

Howard Pezim

Co-Founder and Managing Director

Email: howardp@bedfordgroup.com
Tel: 416-963-9000, ext.223

Recently completed Life Sciences and Healthcare Searches

Disrupting the Downturns

Disrupting the Downturns

Economic slumps as an opportunity to build stronger organizations and amplify value.It’s easy to get caught up in the momentum of bad news. There’s a tipping point for the amount of sour notes we can listen to before the whole song takes on a gloomy vibe. Economic...